Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis.
Koschny R, Holland H, Sykora J, Erdal H, Krupp W, Bauer M, Bockmuehl U, Ahnert P, Meixensberger J, Stremmel W, Walczak H, Ganten TM.
Koschny R, et al.
J Neurooncol. 2010 Apr;97(2):171-85. doi: 10.1007/s11060-009-0010-6. Epub 2009 Sep 20.
J Neurooncol. 2010.
PMID: 19768634